Evidence map›Paper›PMID 34638551›Full record

ArticleInternational journal of molecular sciences2021

Self-Assembly Nanoparticles of Natural Bioactive Abietane Diterpenes.

Epole Ntungwe, Eva María Domínguez-Martín, Gabrielle Bangay, Catarina Garcia, Iris Guerreiro, Eleonora Colombo, Lucilia Saraiva, Ana María Díaz-Lanza, Andreia Rosatella, Marta M Alves and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Epole NtungweCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.
Eva María Domínguez-MartínCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-7884-4292
Gabrielle BangayCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.
Catarina GarciaCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.
Iris GuerreiroCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.
Eleonora ColomboDepartment of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy.
Lucilia SaraivaLAQV-Faculty of Pharmacy of University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.ORCID 0000-0002-9531-4939
Ana María Díaz-LanzaPharmacology Area (Pharmacognosy Laboratory), New Antitumor Compounds: Toxic Action on Leukemia Cells Research Group, Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100-Campus Universitario, 28805 Alcalá de Henares, Spain.ORCID 0000-0002-4216-3997
Andreia RosatellaCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-2691-3110
Marta M AlvesCentro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1, 1049-001 Lisboa, Portugal.ORCID 0000-0002-9679-4022
Catarina Pinto ReisiMed.ULisboa, Faculdade de Farmácia da Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.ORCID 0000-0002-1046-4031
Daniele PassarellaDepartment of Chemistry, University of Milan, Via Golgi 19, 20133 Milano, Italy.ORCID 0000-0001-6180-9581
Patricia RijoCBIOS-Universidade Lusófona's Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0001-7992-8343
Universidad de Alcalá · ESUniversity of Lisbon · PTUniversity of Milan · ITUniversidade do Porto · PTUniversidade Lusófona · PT

Funding

Fundação para a Ciência e a Tecnologia UIDP/04567/2020 and UIDB/04567/2020
6 · The paper itself

Abstract

Different approaches have been reported to enhance penetration of small drugs through physiological barriers; among them is the self-assembly drug conjugates preparation that shows to be a promising approach to improve activity and penetration, as well as to reduce side effects. In recent years, the use of drug-conjugates, usually obtained by covalent coupling of a drug with biocompatible lipid moieties to form nanoparticles, has gained considerable attention. Natural products isolated from plants have been a successful source of potential drug leads with unique structural diversity. In the present work three molecules derived from natural products were employed as lead molecules for the synthesis of self-assembled nanoparticles. The first molecule is the cytotoxic royleanone 7α-acetoxy-6β-hydroxyroyleanone (Roy,

Indexed as

AbietanesAnimalsCell LineChlorocebus aethiopsDrug Delivery SystemsHumansHydrocarbons, BrominatedNanoparticlesOleic AcidPlant ExtractsPlectranthusProdrugsSqualeneToxicity Tests, AcuteVero Cells1-bromododecaneAbietanesHydrocarbons, BrominatedOleic AcidPlant ExtractsProdrugsroyleanoneSqualene1-bromododecanenanoparticlesoleic acidroyleanonesself-assemblysqualene

Identifiers

PMID34638551
PMCPMC8508833
OpenAlexW3201275359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.